Biruh Workeneh is a Nephrology physician affiliated with The University of Texas MD Anderson Cancer Center. OpenAlex indexes 109 publications with 2,698 citations (h-index 23).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingIndustry payments
11 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
11 companies with payments on record in CMS Open Payments (2021 onward), matched to this physician's NPI. The itemized breakdown by company, amount and year is part of the full profile. Why? →
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
42.3%Statin16.2%Atorvastatin Calcium100%Part D<11 patientsLoop diuretic13.5%Furosemide100%Part D<11 patients+ 1 more class in this area
Metabolism & gastrointestinal
39.6%Proton pump inhibitor22.5%Pantoprazole Sodium100%Part D<11 patientsSGLT2 inhibitor17.1%Farxiga100%Part D<11 patientsOther
18%Drugs for treatment of hyperkalemia and hyperphosphatemia18%Auryxia100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Efficacy and Safety of Obinutuzumab in Active Systemic Lupus Erythematosus
New England Journal of Medicine
2026 - The role of the intestinal microbiome in cognitive decline in patients with kidney disease
Nephrology Dialysis Transplantation
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Hagop Kantarjian, MD
The University of Texas MD Anderson Cancer Center
Gabriel Hortobagyi, MD
The University of Texas MD Anderson Cancer Center
Jaffer Ajani, MD
The University of Texas MD Anderson Cancer Center
Funda Meric-Bernstam, MD
The University of Texas MD Anderson Cancer Center
Andrew Levey, MD
Tufts Medical Center
Bertram Kasiske, MD
Hennepin Healthcare
Garabed Eknoyan, MD
Baylor College of Medicine
Lawrence Hunsicker, MD
University of Iowa
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”